Concepedia

B1-01: A multi-centre phase IIB randomized controlled study of BLP25 liposome vaccine (L-BLP25 or Stimuvax) for active specific immunotherapy of non-small cell lung cancer (NSCLC): updated survival analysis

Charles Butts, Andrew W. Maksymiuk, Glenwood Goss, Denis Soulières, Ernie Marshall, Yvon Cormier, Allan Price, Ravinder Sawhney, Nevin Murray

Journal of Thoracic Oncology · 2007 · 47 citations · 0 references

Open access

Concepts

MedicineImmunologyOncologyCancer ImmunologyImmunotherapyVaccinologyAdaptive Immune ModulationCancer ImmunotherapyCancer VaccinesLung Cancer PharmacotherapyPharmacokinetics Of ImmunotherapiesVaccine PlatformsCancer Vaccine DesignCancer Vaccine ImmunologyLiposome ImmunogenicityNon-small Cell Lung Cancer ImmunotherapyNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer Treatment